Cliantha Research Limited is an independent global Contract Research Organization (CRO) providing complete clinical research services. Our integrated clinical offerings includes Phase I/IIa, IIb, III and IV, Bioavailability/Bioequivalence (BA/BE), Clinical Endpoint Trials, Bioanalytical, Biosimilars, Biometrics (including CDISC), Pharmacovigilance, Medical Writing and Personal Healthcare services. Our group companies includes Hill Top Research (US, Canada), Karmic Lifesciences LLP (India) and Inflamax Research (Canada), and as one company Cliantha, we deliver high quality clinical services. Cliantha holds accreditations & approvals from the most respected regulatory agencies including USFDA, EMA, MHRA, TGA, MCC, DCGI, ANSM, AGES, Health Canada, and CAP. In the recent Global Data report - "A Steady Growth of Biosimilars in Clinical Investigations: A 10-Year Retrospective, 2007–2016" published in April 2017, Cliantha secured 4th position based upon the number of Biosimilars trials over a 10-Years period.